Abstract:Background Myopic maculopathy leads to visual function damage.Conventional methods for the identification of choroidal neovascularization (CNV) of myopic maculopathy are fundus fluorescine angiography (FFA) and spectral-domain OCT (SD-OCT),but FFA is an invasive process and SD-OCT is incapable to image CNV well.OCT angiography (OCTA),a novel and non-invasive vascular technique,appears to be dominant in enface imaging of CNV,however,its clinical value remains to be evaluated.Objective This study was to evaluate the application of OCTA in imaging CNV of myopic maculopathy.Methods A prospective serial cases-observational study was performed.Forty-two eyes of 40 patients of myopic maculopathy were included in Ophthalmic Center,Renmin Hospital of Wuhan University from January to October 2015,with the diopter (-10.5 ± 3.74) D.Comperehensive optical and imaginal examinations were carried out in all the eyes,including fundus photography,FFA,SD-OCT and OCTA.Ranibizumab (0.5 mg/0.05 ml) was intravitreally injected in 35 eyes of 35 patients under the informed consent and SD-OCT and OCTA were examined 1 day,1 week and subsequent each month after injection.FFA was examined 1 month after injection.The patients were followed-up for 1-6 months to evaluate the clinical values of OCTA in monitoring the CNV of myopic maculopathy.This study followed the Helsinki Declaration and was approved by the Ethics Committee of Renmin Hospital of Wuhan University.Written informed consent was obtained from each patient prior to any medical examination.Results All the affected eyes showed dye leakage in CNV lesions by FFA and high reflection signal of abnormal choroidal vascular network throughout retinal pigment epithelium by SD-OCT.Clusters of high signal CNV image was clearly visible in the lesions by OCTA,and these signals were able to be displayed on both choriocapillary layer and outer layer of retina more clearly than FFA in 31 eyes of 31 patients.In 35 eyes of 35 patients received intravitreal injection of ranibizumab,CNV images on both choriocapillary layer and outer layer of retina from OCTA shrinked 1 week after injection and the lesions were stable 1 month after injection.Conclusions OCTA can display CNV of myopic maculopathy on the retinal outer layer and choriocapillary layer more clearly than FFA.Significant changes in the CNV net can be observed by OCTA 1 week after intravitreal injection of ranibizumab.OCTA plays an important role during the following-up of CNV therapy.

Optical Coherence Tomography Angiography Of Pathological Myopia Sourced and Idiopathic Choroidal Neovascularization With Follow-Up.

Using Optical Coherence Tomography Angiography (OCTA) to Observe Thecurative Effect of Intravitreal Injection of Ranibizumab for the Treatment of Idiopathic Choroidal Neovascularization (ICNV)

APPLICATION OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY TO ASSESS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN MYOPIC CHOROIDAL NEOVASCULARIZATION.

Clinical values of OCT angiography in imaging of chroidal neovascularization in pathological myopic maculopathy

Optical Coherence Tomography Angiography of Myopic Choroidal Neovascularization Treated by Anti-Vegf Therapy

Retinal microcirculation assessment by oct angiography in a comparative analysis of the course of choroidal neovascularization in pathological myopia and neovascular age-related macular degeneration in association with axial myopia

The use of optical coherence tomography angiography for detecting choroidal neovascularization, compared to standard multimodal imaging

Optical Coherence Tomography Angiography of Inflammatory Choroidal Neovascularization Early Response after Anti-VEGF Treatment

Diagnostic Accuracy of Optical Coherence Tomography Angiography for Choroidal Neovascularization: a Systematic Review and Meta-Analysis

Detection of Myopic Choroidal Neovascularization Using Optical Coherence Tomography Angiography

Optical Coherence Tomography and Fundus Fluorescein Angiography Features of Submacular Choroidal Neovascularization in Pathologic Myopia

Follow-up of nonarteritic anterior ischemic optic neuropathy with optical coherence tomography angiography

Assessment of Three Successive Treatments of Ranibizumab on Neovascular Macular Degeneration by OCT Angiography.

Clinical Observation of Intravitreal Ranibizumab for Treatment of Choroidal Neovascularization Secondary to Pathologic Myopia

Comparison of the efficacy of intravitreal ranibizumab for choroidal neovascularization due to pathological myopia with and without a dome-shaped macula.

Evaluation of macular neovascularization activity in pathological myopia: a comparison between optical coherence tomography and OCT-angiography

Intravitreal Bevacizumab (Avastin) for Myopic Choroidal NeovascularizationSix-Month Results of a Prospective Pilot Study

Spectral domain-optical coherence tomography retinal biomarkers in choroidal neovascularization of multifocal choroiditis, myopic choroidal neovascularization, and idiopathic choroidal neovascularization

Evaluation of Efficacy and Recurrence for Anti-Vascular Endothelial Growth Factor Therapy in Idiopathic Choroidal Neovascularization

Optical coherence tomography angiography characteristics of choroidal neovascularization requiring varied dosing frequencies in treat-and-extend management: An analysis of the AVATAR study

Association Between Subfoveal Choroidal Thickness And Prognoses After Anti-Vascular Endothelial Growth Factor Therapy In Myopic Choroidal Neovascularization